A new survey commissioned by the Lupus Foundation of America (LFA) for Lupus Awareness Month in May, reveals that lupus remains mostly unknown and misunderstood, despite its widespread prevalence.

A recent survey was conducted by TEAM LEWIS on behalf of the Lupus Foundation of America (LFA) to explore American’s awareness and knowledge of lupus. 1,000 individuals in the US, ages 18 or older, ...

Anti-C1q antibodies are a promising marker for the diagnosis and management of lupus nephritis. Immunological tests can differentiate proliferative from non-proliferative lupus nephritis ...

May 23, 2024 — Treatment of autoimmune diseases like lupus has long relied on steroids to knock down the immune system, but more targeted therapies are currently undergoing clinical trials.

PORTSMOUTH, Va. (WAVY) — As we approach Lupus Awareness Month, which starts May 1, 10 On Your Side is taking a closer look at a rare, yet chronic autoimmune disease affecting so many lives.

DESTIN, Fla. — An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according to a speaker at the Congress of Clinical Rheumatology ...

But would you put it in your mouth and swallow it? Some people do, claiming that silver in the form of colloidal supplements is the answer to all manner of ills. Trouble is, it really isn’t ...

Lupus is a disease that tends to be more frequent and more severe in people of non-European ancestry. As such, treatment may work less effectively in these populations. And there are multiple ...

The US regulator has started a review of Roche's supplemental biologics license application (BLA) for Gazyva/Gazyvaro (obinutuzumab) as a treatment for lupus nephritis, with a decision expected in ...

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.